Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
Clinical trial NCT02253316 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02253316
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-20
- Primary completion
- 2020-02-05
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.